SPAPLUS

Complement C3, Antigen, Antiserum, Control

THE BINDING SITE GROUP, LTD.

The following data is part of a premarket notification filed by The Binding Site Group, Ltd. with the FDA for Spaplus.

Pre-market Notification Details

Device IDK100179
510k NumberK100179
Device Name:SPAPLUS
ClassificationComplement C3, Antigen, Antiserum, Control
Applicant THE BINDING SITE GROUP, LTD. Los Angele,  CA  90025 -7121
ContactJay Geller
CorrespondentJay Geller
THE BINDING SITE GROUP, LTD. Los Angele,  CA  90025 -7121
Product CodeCZW  
CFR Regulation Number866.5240 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2010-01-21
Decision Date2010-08-13
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
05051700017596 K100179 000
05051700015578 K100179 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.